Approvals for injectable vaccines for COVID-19 are starting to build, but non-injectables like oral and intranasal vaccines could be required if the pandemic is to be fought across all areas of ...
The California Department of Public Health (CDPH) on January 3 warned that the state's pertussis (whooping cough) cases are ...
CWD is an always-fatal prion disease affecting elk, moose, reindeer, and deer. It was first detected in North America in 1967 ...
Vaccines protect babies and children from potentially life-threatening diseases. Widespread childhood vaccination has reduced or eliminated deadly diseases like polio and smallpox. Vaccines currently ...
Most commercial vaccines currently available are delivered by injection, which has some limitation for mass immunization, especially in resource-poor developing countries. Oral vaccines have ...
The long-awaited, specially developed oral vaccine for Namibian kudus against rabies has finally arrived in the country after a lengthy wait. According to the Namibia Agricultural If you are an active ...
In February, the World Health Organization reported that its stock of oral cholera vaccines, or OCV, was empty. It was replenished by South Korean biopharmaceutical company EuBiologics but ...
A new pentavalent rotavirus vaccine (PRV, RotaTeq™) was licensed in 2006 and its safety is currently under postmarketing monitoring. [82] Nevertheless, several other oral vaccines are at various ...
a private Michigan-based biotechnology company specializing in innovative circular RNA technologies announced today that DynPort Vaccine Company LLC (DVC), a General Dynamics Information Technology ...
Vaccinations are available on a first-come, first-served basis. For dogs, the shelter offers Rabies, Distemper, and Bordetella vaccines. Cats can receive Rabies and Distemper vaccinations. Prices are ...
Panacea Biotec announced that it was awarded a contract from United Nations International Children's Emergency Fund (UNICEF) to supply 115 million doses of its bivalent oral polio vaccine (bOPV) worth ...
Pursuant to the Project Agreement, the Company receives funding for a Phase 2b comparative study evaluating the Company’s oral pill XBB COVID-19 vaccine candidate against an mRNA vaccine ...